Further analysis using the 675 cases from the TCGA-LGG (low-grade glioma) dataset showed a similar trend to the CGGA datasets (Figure S1B), indicating that aberrant expression of YKL-40 strongly influences lower stages of glioma other than GBM. The gene discussed is CHI3L1; the disease is glioma.